Novavax | NVAX - Passivo Circulante





Passivo Circulante Alterar Data
Adma Biologics USD 75.76M 2.22M 2026-06
Agenus USD 231.82M 17.42M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
BioCryst Pharmaceuticals USD 208.85M 13.46M 2026-06
Cassava Sciences USD 40.11M 3.72M 2026-03
Geron USD 70.33M 3.24M 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
MannKind USD 142.9M 8.34M 2026-06
Merck USD 27.73B 786M 2026-06
Minerva Neurosciences USD 2.29M 381K 2025-12
Moderna USD 2.53B 139M 2026-06
Novartis USD 31.37B 4.1B 2026-03
Novavax USD 330.57M 11.89M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
TG Therapeutics USD 268.49M 81.38M 2026-06